Francesco Pezzella - Publications

Affiliations: 
University of Oxford, Oxford, United Kingdom 

69 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Ribatti D, Pezzella F. Vascular Co-Option and Other Alternative Modalities of Growth of Tumor Vasculature in Glioblastoma. Frontiers in Oncology. 12: 874554. PMID 35433447 DOI: 10.3389/fonc.2022.874554  0.301
2021 Fanfani V, Citi L, Harris AL, Pezzella F, Stracquadanio G. The landscape of the heritable cancer genome. Cancer Research. PMID 33731442 DOI: 10.1158/0008-5472.CAN-20-3348  0.342
2020 Fanfani V, Zatopkova M, Harris AL, Pezzella F, Stracquadanio G. Dissecting the heritable risk of breast cancer: from statistical methods to susceptibility genes. Seminars in Cancer Biology. PMID 32569822 DOI: 10.1016/j.semcancer.2020.06.001  0.354
2018 Donnem T, Reynolds AR, Kuczynski EA, Gatter K, Vermeulen PB, Kerbel RS, Harris AL, Pezzella F. Non-angiogenic tumours and their influence on cancer biology. Nature Reviews. Cancer. PMID 29520090 DOI: 10.1038/Nrc.2018.14  0.431
2017 Suh YE, Lawler K, Henley-Smith R, Pike L, Leek R, Barrington S, Odell EW, Ng T, Pezzella F, Guerrero-Urbano T, Tavassoli M. Association between hypoxic volume and underlying hypoxia-induced gene expression in oropharyngeal squamous cell carcinoma. British Journal of Cancer. PMID 28324887 DOI: 10.1038/bjc.2017.66  0.618
2016 Adighibe O, Leek RD, Fernandez-Mercado M, Hu J, Snell C, Gatter KC, Harris AL, Pezzella F. Why some tumours trigger neovascularisation and others don't: the story thus far. Chinese Journal of Cancer. 35: 18. PMID 26873439 DOI: 10.1186/s40880-016-0082-6  0.785
2016 Tan K, Haider S, Zois C, Turley H, Leek R, Harris A, Buffa F, Acuto O, Pezzella F. NUB1 protein regulates cullins and E3 ligases in estrogen receptor negative breast cancers European Journal of Cancer. 61: S190. DOI: 10.1016/S0959-8049(16)61672-6  0.696
2015 Pezzella F, Harris AL, Tavassoli M, Gatter KC. Blood vessels and cancer much more than just angiogenesis. Cell Death Discovery. 1: 15064. PMID 27551488 DOI: 10.1038/cddiscovery.2015.64  0.375
2014 Kato T, Pezzella F, Steers G, Campo L, Leek RD, Turley H, Kameoka S, Nishikawa T, Harris AL, Gatter KC, Fox S. Blood vessel invasion and other variables as predictors of long-term survival in Japanese and British patients with primary invasive breast cancer. International Journal of Clinical and Experimental Pathology. 7: 7967-78. PMID 25550840  0.779
2014 Adighibe O, Turley H, Leek R, Harris A, Coutts AS, La Thangue N, Gatter K, Pezzella F. JMY protein, a regulator of P53 and cytoplasmic actin filaments, is expressed in normal and neoplastic tissues. Virchows Archiv : An International Journal of Pathology. 465: 715-22. PMID 25280461 DOI: 10.1007/s00428-014-1660-0  0.779
2014 Pezzella F, Harris AL. When cancer co-opts the vasculature. The New England Journal of Medicine. 370: 2146-7. PMID 24869725 DOI: 10.1056/NEJMcibr1402407  0.343
2014 Agorreta J, Hu J, Liu D, Delia D, Turley H, Ferguson DJ, Iborra F, Pajares MJ, Larrayoz M, Zudaire I, Pio R, Montuenga LM, Harris AL, Gatter K, Pezzella F. TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC. Molecular Cancer Research : McR. 12: 660-9. PMID 24567527 DOI: 10.1158/1541-7786.MCR-13-0481  0.643
2014 Snell CE, Turley H, McIntyre A, Li D, Masiero M, Schofield CJ, Gatter KC, Harris AL, Pezzella F. Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours. Plos One. 9: e88955. PMID 24563687 DOI: 10.1371/Journal.Pone.0088955  0.809
2014 Abdulla Z, Turley H, Gatter K, Pezzella F. Immunohistological recognition of cyclin D1 expression by non-lymphoid cells among lymphoid neoplastic cells. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 122: 183-91. PMID 23758159 DOI: 10.1111/apm.12123  0.558
2014 Snell CE, Turley H, McIntyre A, Li D, Masiero M, Schofield CJ, Gatter KC, Harris AL, Pezzella F. Expression of proline-hydroxylated HIF-1α predicts poorer overall survival in primary breast cancer. Plos One. DOI: 10.1371/Journal.Pone.0088955.G005  0.778
2013 Donnem T, Hu J, Ferguson M, Adighibe O, Snell C, Harris AL, Gatter KC, Pezzella F. Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment? Cancer Medicine. 2: 427-36. PMID 24156015 DOI: 10.1002/cam4.105  0.708
2013 Giatromanolaki A, Koukourakis MI, Pouliliou S, Gatter KC, Pezzella F, Harris AL, Sivridis E. Overexpression of LC3A autophagy protein in follicular and diffuse large B-cell lymphomas. Hematology/Oncology and Stem Cell Therapy. 6: 20-5. PMID 23664601 DOI: 10.1016/j.hemonc.2013.02.001  0.604
2013 Kashima TG, Turley H, Dongre A, Pezzella F, Athanasou NA. Diagnostic utility of aP2/FABP4 expression in soft tissue tumours. Virchows Archiv : An International Journal of Pathology. 462: 465-72. PMID 23511993 DOI: 10.1007/s00428-013-1392-6  0.579
2012 Biswas S, Charlesworth PJ, Turner GD, Leek R, Thamboo PT, Campo L, Turley H, Dildey P, Protheroe A, Cranston D, Gatter KC, Pezzella F, Harris AL. CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC. Carcinogenesis. 33: 1717-25. PMID 22777959 DOI: 10.1093/carcin/bgs222  0.79
2011 Jubb AM, Cesario A, Ferguson M, Congedo MT, Gatter KC, Lococo F, Mulè A, Pezzella F. Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases. British Journal of Cancer. 104: 1877-81. PMID 21540863 DOI: 10.1038/bjc.2011.147  0.666
2010 Biswas S, Troy H, Leek R, Chung YL, Li JL, Raval RR, Turley H, Gatter K, Pezzella F, Griffiths JR, Stubbs M, Harris AL. Effects of HIF-1alpha and HIF2alpha on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts. Journal of Oncology. 2010: 757908. PMID 20652061 DOI: 10.1155/2010/757908  0.76
2010 Liu D, Hu J, Agorreta J, Cesario A, Zhang Y, Harris AL, Gatter K, Pezzella F. Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases. Cancer Letters. 296: 194-205. PMID 20471161 DOI: 10.1016/j.canlet.2010.04.017  0.43
2009 Jubb AM, Turley H, Moeller HC, Steers G, Han C, Li JL, Leek R, Tan EY, Singh B, Mortensen NJ, Noguera-Troise I, Pezzella F, Gatter KC, Thurston G, Fox SB, et al. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer. British Journal of Cancer. 101: 1749-57. PMID 19844231 DOI: 10.1038/sj.bjc.6605368  0.824
2009 Turley H, Steers G, Li JL, Sainson R, Harris AL, Pezzella F, Gatter KC. Corrigendum. Histopathology. 55: 463-4. PMID 19817897 DOI: 10.1111/j.1365-2559.2009.03412.x  0.75
2009 Martinez JC, Müller MM, Turley H, Steers G, Choteau L, Li JL, Sainson R, Harris AL, Pezzella F, Gatter KC. Nuclear and membrane expression of the angiogenesis regulator delta-like ligand 4 (DLL4) in normal and malignant human tissues. Histopathology. 54: 598-606. PMID 19413639 DOI: 10.1111/j.1365-2559.2009.03279.x  0.797
2009 Tan EY, Yan M, Campo L, Han C, Takano E, Turley H, Candiloro I, Pezzella F, Gatter KC, Millar EK, O'Toole SA, McNeil CM, Crea P, Segara D, Sutherland RL, et al. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. British Journal of Cancer. 100: 405-11. PMID 19165203 DOI: 10.1038/sj.bjc.6604844  0.746
2008 Giatromanolaki A, Koukourakis MI, Pezzella F, Sivridis E, Turley H, Harris AL, Gatter KC. Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins. Leukemia & Lymphoma. 49: 2181-6. PMID 19021062 DOI: 10.1080/10428190802450629  0.757
2008 Giatromanolaki A, Koukourakis MI, Pezzella F, Sivridis E, Turley H, Harris AL, Gatter KC. Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation. Hematological Oncology. 26: 219-24. PMID 18461646 DOI: 10.1002/hon.861  0.767
2008 Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Harris AL. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. British Journal of Haematology. 141: 672-5. PMID 18318758 DOI: 10.1111/j.1365-2141.2008.07077.x  0.379
2008 Giatromanolaki A, Koukourakis MI, Pezzella F, Turley H, Sivridis E, Bouros D, Bougioukas G, Harris AL, Gatter KC. Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway. Cancer Letters. 262: 87-93. PMID 18187257 DOI: 10.1016/j.canlet.2007.11.041  0.743
2007 Tan EY, Campo L, Han C, Turley H, Pezzella F, Gatter KC, Harris AL, Fox SB. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer. Breast Cancer Research : Bcr. 9: R89. PMID 18096060 DOI: 10.1186/bcr1838  0.77
2007 Kato T, Steers G, Campo L, Roberts H, Leek RD, Turley H, Kimura T, Kameoka S, Nishikawa T, Kobayashi M, Harris AL, Gatter KC, Pezzella F. Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer. British Journal of Cancer. 97: 1277-86. PMID 17923874 DOI: 10.1038/sj.bjc.6604015  0.742
2007 Trivella M, Pezzella F, Pastorino U, Harris AL, Altman DG. Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data. The Lancet. Oncology. 8: 488-99. PMID 17513172 DOI: 10.1016/S1470-2045(07)70145-6  0.426
2007 Sington J, Giatromanolaki A, Campo L, Turley H, Pezzella F, Gatter KC. BNIP3 expression in follicular lymphoma. Histopathology. 50: 555-60. PMID 17394490 DOI: 10.1111/j.1365-2559.2007.02657.x  0.579
2007 Tan EY, Campo L, Han C, Turley H, Pezzella F, Gatter KC, Harris AL, Fox SB. BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 467-74. PMID 17255267 DOI: 10.1158/1078-0432.CCR-06-1466  0.755
2006 Adam PJ, Terrett JA, Steers G, Stockwin L, Loader JA, Fletcher GC, Lu LS, Leach BI, Mason S, Stamps AC, Boyd RS, Pezzella F, Gatter KC, Harris AL. CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding. British Journal of Cancer. 95: 298-306. PMID 16892042 DOI: 10.1038/sj.bjc.6603222  0.393
2006 Blazquez C, Cook N, Micklem K, Harris AL, Gatter KC, Pezzella F. Phosphorylated KDR can be located in the nucleus of neoplastic cells. Cell Research. 16: 93-8. PMID 16467880 DOI: 10.1038/sj.cr.7310012  0.393
2005 Kato T, Prevo R, Steers G, Roberts H, Leek RD, Kimura T, Kameoka S, Nishikawa T, Kobayashi M, Jackson DG, Harris AL, Gatter KC, Pezzella F. A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity. British Journal of Cancer. 93: 1168-74. PMID 16251871 DOI: 10.1038/sj.bjc.6602844  0.708
2005 Zhang Y, Pillai G, Gatter K, Blázquez C, Turley H, Pezzella F, Watt SM. Expression and cellular localization of vascular endothelial growth factor A and its receptors in acute and chronic leukemias: an immunohistochemical study. Human Pathology. 36: 797-805. PMID 16084950 DOI: 10.1016/j.humpath.2005.05.015  0.623
2005 Daniels RA, Turley H, Kimberley FC, Liu XS, Mongkolsapaya J, Ch'en P, Xu XN, Jin B, Pezzella F, Screaton GR. Expression of TRAIL and TRAIL receptors in normal and malignant tissues Cell Research. 15: 430-438. PMID 15987601 DOI: 10.1038/sj.cr.7290311  0.62
2005 Couvelard A, O'Toole D, Leek R, Turley H, Sauvanet A, Degott C, Ruszniewski P, Belghiti J, Harris AL, Gatter K, Pezzella F. Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. Histopathology. 46: 668-76. PMID 15910598 DOI: 10.1111/j.1365-2559.2005.02160.x  0.765
2005 Campo L, Turley H, Han C, Pezzella F, Gatter KC, Harris AL, Fox SB. Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival. The Journal of Pathology. 205: 585-91. PMID 15776477 DOI: 10.1002/path.1740  0.755
2005 Pillai G, Cook N, Turley H, Leek RD, Blasquez C, Pezzella F, Harris AL, Gatter KC. The expression and cellular localization of phosphorylated VEGFR2 in lymphoma and non-neoplastic lymphadenopathy: an immunohistochemical study. Histopathology. 46: 209-16. PMID 15693894 DOI: 10.1111/j.1365-2559.2005.02081.x  0.758
2005 Hu J, Bianchi F, Ferguson M, Cesario A, Margaritora S, Granone P, Goldstraw P, Tetlow M, Ratcliffe C, Nicholson AG, Harris A, Gatter K, Pezzella F. Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer. Oncogene. 24: 1212-9. PMID 15592519 DOI: 10.1038/sj.onc.1208242  0.472
2005 Couvelard A, O'Toole D, Turley H, Leek R, Sauvanet A, Degott C, Ruszniewski P, Belghiti J, Harris AL, Gatter K, Pezzella F. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. British Journal of Cancer. 92: 94-101. PMID 15558070 DOI: 10.1038/sj.bjc.6602245  0.797
2004 Stewart M, Turley H, Cook N, Pezzella F, Pillai G, Ogilvie D, Cartlidge S, Paterson D, Copley C, Kendrew J, Barnes C, Harris AL, Gatter KC. The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study. Histopathology. 43: 33-9. PMID 12823710 DOI: 10.1046/j.1365-2559.2003.01644.x  0.661
2003 Sardari Nia P, Stessels F, Pezzella F, Vermeulen PB, van Marck EA, van Schil P. Growth index is independent of microvessel density in non-small cell lung carcinomas. Human Pathology. 34: 959-60; author reply. PMID 14562297 DOI: 10.1016/S0046-8177(03)00247-8  0.406
2003 Adam PJ, Berry J, Loader JA, Tyson KL, Craggs G, Smith P, De Belin J, Steers G, Pezzella F, Sachsenmeir KF, Stamps AC, Herath A, Sim E, O'Hare MJ, Harris AL, et al. Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. Molecular Cancer Research : McR. 1: 826-35. PMID 14517345  0.448
2003 Passalidou E, Stewart M, Trivella M, Steers G, Pillai G, Dogan A, Leigh I, Hatton C, Harris A, Gatter K, Pezzella F. Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma. British Journal of Cancer. 88: 553-9. PMID 12592369 DOI: 10.1038/sj.bjc.6600742  0.308
2003 Pelosi G, Pastorino U, Pasini F, Maissoneuve P, Fraggetta F, Iannucci A, Sonzogni A, De Manzoni G, Terzi A, Durante E, Bresaola E, Pezzella F, Viale G. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. British Journal of Cancer. 88: 537-47. PMID 12592367 DOI: 10.1038/sj.bjc.6600731  0.333
2002 Hui EP, Chan AT, Pezzella F, Turley H, To KF, Poon TC, Zee B, Mo F, Teo PM, Huang DP, Gatter KC, Johnson PJ, Harris AL. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 2595-604. PMID 12171890  0.688
2002 Pezzella F, Harris AL, Gatter KC. Ways of escape: are all tumours angiogenic? Histopathology. 39: 551-3. PMID 11903570 DOI: 10.1046/j.1365-2559.2001.01027.x  0.394
2002 Stewart M, Talks K, Leek R, Turley H, Pezzella F, Harris A, Gatter K. Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma. Histopathology. 40: 253-60. PMID 11895491 DOI: 10.1046/j.1365-2559.2002.01357.x  0.813
2002 Leek RD, Talks KL, Pezzella F, Turley H, Campo L, Brown NS, Bicknell R, Taylor M, Gatter KC, Harris AL. Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. Cancer Research. 62: 1326-9. PMID 11888900  0.807
2002 Passalidou E, Trivella M, Singh N, Ferguson M, Hu J, Cesario A, Granone P, Nicholson AG, Goldstraw P, Ratcliffe C, Tetlow M, Leigh I, Harris AL, Gatter KC, Pezzella F. Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas. British Journal of Cancer. 86: 244-9. PMID 11870514 DOI: 10.1038/sj.bjc.6600015  0.338
2001 Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, Gatter KC, Harris AL. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. British Journal of Cancer. 85: 881-90. PMID 11556841 DOI: 10.1054/bjoc.2001.2018  0.83
2000 Pruneri G, Bertolini F, Soligo D, Carboni N, Cortelezzi A, Ferrucci PF, Buffa R, Lambertenghi-Deliliers G, Pezzella F. Angiogenesis in myelodysplastic syndromes. British Journal of Cancer. 81: 1398-401. PMID 10604739 DOI: 10.1038/sj.bjc.6693515  0.356
1997 Pezzella F, Di Bacco A, Andreola S, Nicholson AG, Pastorino U, Harris AL. Angiogenesis in primary lung cancer and lung secondaries. European Journal of Cancer (Oxford, England : 1990). 2494-500. PMID 9059338 DOI: 10.1016/S0959-8049(96)00377-2  0.33
1997 Barbareschi M, Caffo O, Veronese S, Leek RD, Fina P, Fox S, Bonzanini M, Girlando S, Morelli L, Eccher C, Pezzella F, Doglioni C, Dalla Palma P, Harris A. Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. Human Pathology. 27: 1149-55. PMID 8912823 DOI: 10.1016/S0046-8177(96)90307-X  0.712
1996 Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. European Journal of Cancer (Oxford, England : 1990). 32: 2474-84. PMID 9059336 DOI: 10.1016/S0959-8049(96)00379-6  0.459
1996 Korkolopoulou P, Kaklamanis L, Pezzella F, Harris AL, Gatter KC. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. British Journal of Cancer. 73: 148-53. PMID 8546899 DOI: 10.1038/bjc.1996.28  0.339
1995 Kocialkowski S, Pezzella F, Morrison H, Jones M, Laha S, Harris AL, Mason DY, Gatter KC. Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma. British Journal of Haematology. 89: 55-60. PMID 7833277 DOI: 10.1111/j.1365-2141.1995.tb08911.x  0.373
1995 Caffo O, Barbareschi M, Veronese S, Pezzella F, Leek R, Fox S, Harris A, Dalla Palma P. 686 BCL2 expression in node-negative breast carcinoma: A study on a series of 190 cases with long-term follow-up European Journal of Cancer. 31: S143. DOI: 10.1016/0959-8049(95)95936-Z  0.702
1994 Piris MA, Pezzella F, Martinez-Montero JC, Orradre JL, Villuendas R, Sanchez-Beato M, Cuena R, Cruz MA, Martinez B, Pezella F [corrected to Pezzella F]. p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time. British Journal of Cancer. 69: 337-41. PMID 8297731 DOI: 10.1038/bjc.1994.61  0.322
1994 Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. British Journal of Cancer. 69: 135-9. PMID 8286195 DOI: 10.1038/bjc.1994.22  0.699
1994 Pezzella F, Micklem K, Turley H, Pulford K, Jones M, Kocialkowski S, Delia D, Aiello A, Bicknell R, Smith K. Antibody for detecting p53 protein by immunohistochemistry in normal tissues. Journal of Clinical Pathology. 47: 592-6. PMID 8089212 DOI: 10.1136/jcp.47.7.592  0.553
1993 Pezzella F, Morrison H, Jones M, Gatter KC, Lane D, Harris AL, Mason DY. Immunohistochemical detection of p53 and bcl‐2 proteins in non‐Hodgkin's lymphoma Histopathology. 22: 39-44. PMID 8436340 DOI: 10.1111/J.1365-2559.1993.Tb00067.X  0.435
1993 Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Mason DY. bcl-2 protein in non-small-cell lung carcinoma. The New England Journal of Medicine. 329: 690-4. PMID 8393963 DOI: 10.1056/NEJM199309023291003  0.596
1992 Pezzella F, Turley H, Kuzu I, Gatter KC, Mason DY, Harris A. Reversible p53 expression in lung cancer. Lancet (London, England). 340: 922. PMID 1357342 DOI: 10.1016/0140-6736(92)93342-K  0.574
Show low-probability matches.